# AG1, Ritual, and Blueland fund third-party clinical studies to convert skeptical buyers at scale

*Modern Retail reports DTC health and home brands are commissioning independent research to prove product claims and accelerate growth.*

By **Jenny Huang Goodman MPA MSc MHSA, Principal** — The Stash Edge, Hako Shikin LLC.
Published 2026-09-07.

Canonical: https://www.pops4.com/stash/articles/ag1-ritual-blueland-aggregate-pattern-2026-09-07t09-6
Subject: AG1, Ritual, Blueland (aggregate pattern)
Tags: clinical studies, third-party validation, dtc, health products, brand credibility, conversion optimization

---

AG1, Ritual, and Blueland are paying universities and third-party labs to run clinical studies on their products, then publishing the results as conversion fuel. According to Modern Retail, executives at these brands identify independent validation as a primary growth lever, distinct from internal testing or testimonial-based proof.

The mechanism is transactional: a brand commissions a study through an academic institution or contract research organization, waits for peer-reviewed publication or pre-publication clearance, then integrates findings into product pages, ad creative, and email flows. AG1 has cited third-party studies in multiple product launches. Ritual publishes study summaries on individual ingredient pages. Blueland references environmental impact data validated by outside labs in direct-response campaigns. Each brand treats the research not as compliance theater but as a conversion asset with measurable return.

The play works because it interrupts the default skepticism around wellness and sustainability claims. A brand can say its probiotic improves gut health or its tablet reduces plastic waste, but a buyer who has been burned by past promises discounts the statement. A published study from a university moves the claim from marketing copy to documented evidence. The buyer does not need to trust the brand; she can trust the institution that ran the trial. That shift closes the gap between interest and purchase, particularly in categories where efficacy is subjective and buyer education is incomplete.

The cost is non-trivial but scalable. A small observational study through a university lab runs **$15,000 to $50,000** depending on duration and sample size. A blinded, controlled trial with human subjects can reach **$100,000 to $300,000**. Brands with revenue above **$10 million** can absorb this as a line item in product development. The study becomes an asset with multi-year shelf life, deployed across channels without ongoing media spend. Modern Retail noted that brands view the investment as comparable to a six-month paid acquisition campaign, but with compounding credibility instead of decaying reach.

A small physical-product brand can run the same play at reduced scale. Start with a formulation claim that is specific and measurable: a moisturizer reduces transepidermal water loss by a certain percentage, a cleaning concentrate outperforms a category benchmark on bacterial reduction, a supplement increases serum levels of a target nutrient. Contact a contract research organization that works with emerging brands—firms like Citrus Labs, BioScreen, or regional university research offices—and request a quote for a pilot study with **20 to 50 participants** over **30 to 60 days**. Budget **$10,000 to $25,000**. Specify that results will be published or made available in summary form with institutional attribution. Once complete, convert the findings into a one-page PDF for the product page, a 15-second claim for video creative, and a paragraph for Amazon A+ content. The study does not need to appear in a major journal; it needs to be real, third-party, and cited.

The broader pattern is that proof is now a product feature. Buyers in health, home, and personal care categories expect evidence beyond ingredient lists and founder stories. Brands that commission and publish independent research are building a moat that testimonials and influencer partnerships cannot replicate. The study is the new ingredient deck.

## The takeaway

Commission a third-party study on one measurable product claim, then deploy the results as a conversion asset across every channel.

---

## Publisher

**Hako Shikin LLC** — Virginia Beach, Virginia. Founded 1997. ASI 217876 · DUNS 18-204-6339.
Principal and author: **Jenny Huang Goodman MPA MSc MHSA**.

- Author: https://www.huanggoodman.com/about
- LLM context: https://www.pops4.com/stash/llms.txt
- MCP endpoint, for AI agents: https://mcp.pops4.com/mcp
- Client dashboard: https://dashboard.pops4.com/
- Catalogue: 70,000+ products, 200+ brands